Lidofast

Lidocaine Hydrochloride, the active ingredient in Lidofast, is a local anesthetic presented as a topical formulation for local use. It provides temporary numbness for minor surgical, dental and superficial skin procedures in adult patients.

GNH USA supplies Lidofast as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidofast (lidocaine hydrochloride) is used within the local anesthetic pathway to produce reversible loss of sensation in targeted tissues. - Minor surgical procedures: provides localized numbness to facilitate surgery. - Dental procedures: numbs oral tissues to reduce pain during treatment. - Superficial skin procedures: relieves pain during minor skin interventions such as biopsies or laser therapy.

Lidofast may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the application site. - Tingling or numbness beyond the intended area. - Redness or mild swelling of the skin. - Dizziness or light‑headedness. - Headache. - Nausea.

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling, bronchospasm). - Systemic toxicity presenting as seizures or cardiac arrhythmia. - Methemoglobinemia. - Severe skin reactions such as Stevens‑Johnson syndrome. - Respiratory depression. - Cardiovascular collapse.

Before using Lidofast, consider the following safety measures. - Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Application area: limit use to intact skin or mucosa; avoid broken skin to reduce systemic absorption. - Dosage limit: adhere to the recommended maximum dose for the specific formulation. - Concomitant medications: exercise caution when combined with other local anesthetics or agents affecting cardiac conduction. - Patient monitoring: observe for signs of central nervous system or cardiovascular toxicity during extensive use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidofast can interact with other medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma lidocaine levels and toxicity risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can reduce lidocaine metabolism. - Concurrent use of other local anesthetics: additive neuro‑cardiac toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of lidocaine toxicity. - Loop diuretics (e.g., furosemide): may alter protein binding and increase free drug. - General anesthetics (e.g., propofol, inhalational agents): may potentiate central nervous system depression.